Skip to main content

Complications in the Cosmetic Use of Botulinum Toxin Type A: Prevention and Management

  • Chapter
  • First Online:
Complications in Maxillofacial Cosmetic Surgery

Abstract

Botulinum toxin type A (BTX-A) has become the most frequently requested nonsurgical procedure performed around the world. The use of BTX-A in cosmetics has expanded greatly since its approval by the Food and Drug Administration for reduction of glabellar rhytids. Experienced clinicians have been using BTX-A in other areas off-label to improve the appearance of rhytids and facial harmony. Adverse effects associated with BTX-A are rare and tend to be mild and temporary, such as bruising, swelling, and pain at injection sites. More serious complications, such as brow ptosis or eyelid ptosis, can occur. These complications can be minimized by a thorough understanding of the anatomy of the face and careful injection technique, which will be outlined in this article.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

References

  1. Qaqish C. Botulinum toxin use in the upper face. Atlas Oral Maxillofacial Surg Clin N Am. 2016;24:95–103.

    Article  Google Scholar 

  2. Carruthers J, Fagien S, Mattarasso SL, et al. Consensus recommendations on the use of botulinum toxin type A in facial aesthetics. Plast Reconst Surg. 2004;114:1S–22S.

    Article  PubMed  Google Scholar 

  3. Coleman K, Carruthers J. Combination therapy with Botox and fillers: the new rejuvenation paradigm. Dermatol Ther. 2006;19:177–88.

    Article  PubMed  Google Scholar 

  4. Carruthers J, Carruthers A. Botulinum toxin in facial rejuvenation: an update. Dermatol Clin. 2009;27(4):417–25.

    Article  CAS  PubMed  Google Scholar 

  5. American Society of Plastic Surgeons. New statistics reflect the changing face of plastic surgery. https://www.plasticsurgery.org/news/press-releases/new-statistics-reflect-the-changing-face-of-plastic-surgery

  6. Tremaine AM, McCullough JL. Botulinum toxin type A for the management of glabellar rhytids. Clin Cosmet Investig Dermatol. 2013;3:15–23.

    Google Scholar 

  7. Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins. 2013;5(2):249–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Carruthers JDA, Carruthers JA. Treatment of glabellar frown lines with C. Botulinum A exotoxin. In: Carruthers J, Carruthers A. Botulinum toxin in facial rejuvenation: an update.

    Google Scholar 

  9. Botox Cosmetic OnabotulinumtoxinA: full prescribing information. Allergan Inc. 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/103000s5236lbl.pdf

  10. Xeomin IncobotulinumtoxinA: full prescribing information. Merz Pharmaceuticals, LLC. 2010. http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125360lbl.pdf

  11. Dysport AbobotulinumtoxinA: full prescribing information. Ipsen Pharmaceuticals and Galderma Laboratories. 2016. https://www.dysport.com/pdfs/Dysport_Full_Prescribing_Information.pdf.

  12. Chen JJ, Dashtipour K. Abo-, inco-, ona-, and rima-botulinum toxins in clinical therapy: a primer. Pharmacotherapy. 2013;33(3):304–18.

    Article  CAS  PubMed  Google Scholar 

  13. Klein AW. Contraindications and complications with the use of botulinum toxin. Clin Dermatol. 2004;22(1):66–75.

    Article  PubMed  Google Scholar 

  14. Matarasso SL, Matarasso A. Treatment guidelines for botulinum toxin type A for the periocular region and a report on partial upper lip ptosis following injections to the lateral canthal rhytids. Plast Reconstr Surg. 2001;108(1):215–7.

    Article  Google Scholar 

  15. Rzany B, Zielke H. Safety of botulinum toxin in aesthetic medicine. In: Botulinum toxin in aesthetic medicine. Berlin: Springer; 2007. p. 119–25.

    Google Scholar 

  16. Klein AW. Complications, adverse reactions, and insights with the use of botulinum toxin. Dermatol Surg. 2003;29(5):548–56.

    Google Scholar 

  17. Brodsky MA, Swope DM, Grimes D. Diffusion of botulinum toxins. In: Louis ED, editor. Tremor Other Hyperkinet Mov. 2012;2:tre-02-85-417-1.

    Google Scholar 

  18. Matarasso A, Shafer D. Botulinum toxin injections for facial rejuvenation. In: Nahai F, editor. The art of aesthetic surgery: principles and techniques. 2nd ed. St Louis, MO: Quality Medicine Publishing; 2011. p. 243–6. (4 in Qaquish).

    Google Scholar 

  19. Sorensen EP, Urman C. Cosmetic complications: rare and serious events following botulinum toxin and soft tissue filler administration. J Drugs Dermatol. 2015;14(5):486–91.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Whitney Florin M.D., D.D.S. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Florin, W., Haiavy, J. (2018). Complications in the Cosmetic Use of Botulinum Toxin Type A: Prevention and Management. In: Ferneini, E., Castiglione, C., Banki, M. (eds) Complications in Maxillofacial Cosmetic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-58756-1_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58756-1_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58755-4

  • Online ISBN: 978-3-319-58756-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics